ImpediMed Limited
IPDQF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 26.6% | -11.4% | 8.1% | – |
| Gross Profit | $0 | $0 | -$0 | $0 |
| % Margin | 86.3% | 86.9% | -120.4% | 83.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -138% | -219.3% | -180.7% | -178.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -182.6% | -196.9% | -180.9% | -189.4% |
| EPS Diluted | -0.012 | -0.01 | -0.011 | -0.012 |
| % Growth | -17.3% | 14% | 3.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |